Rubicon Organics #shorts s #stockmarket #stocks

A new so­cial me­dia cam­paign from Ab­b­Vie and a Parkin­son’s dis­ease non­prof­it wants to “flip the switch” for pa­tients and care­givers. The Ab­b­Vie Face­book and

Oncolytics’s pelareorep is an intravenously delivered oncolytic reovirus that specifically targets cancer cells and induces inflammatory responses. Image credit: MiniStocker / Shutterstock. Oncolytics Biotech is

Leqembi won full FDA approval last July as a 100mg/mL injection for intravenous (IV) use as Eisai and Biogen pursue a monthly dosing regimen. Image